Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations
Clinical Research and Regulatory Affairs · 2006
DOI: 10.1080/10601330601079851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research and Regulatory Affairs, 2006. Verfasst von Jonathon M. Parker. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
For new chemical entities, assessing a compound's abuse potential is an important component of the drug development process. To ensure regulators make the correct evaluation of a compound's abuse liability, it is vital for pharmaceutical companies to understand the appropriate preapproval measures for assessing a new chemical entity's abuse potential and the required registration procedures for making the recommendation. The goal of this review is to present an overview of the scheduling process as it relates to drug development and marketing registration.
Zitieren
APA
Parker, J. M. (2006). Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations. Clinical Research and Regulatory Affairs. https://doi.org/10.1080/10601330601079851
Vancouver
Parker JM. Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations. Clinical Research and Regulatory Affairs. 2006. doi:10.1080/10601330601079851
BibTeX
@article{Parker2006,
author = {Parker, Jonathon M.},
title = {Overview of Drug Control: A Regulatory Primer on Scheduling and Controlled Substance Regulations},
journal = {Clinical Research and Regulatory Affairs},
year = {2006},
doi = {10.1080/10601330601079851}
}
EUVIMED